526. Deputy Conor Sheehan asked the Minister for Health the way in which the commitments in the National Rare Disease Strategy 2025 – 2030 are being applied to the approval process for the drug Skyclarys used to treat Friedrich's ataxia to prevent further delays in addressing the unmet need of sufferers; and if she will make a statement on the matter. [17918/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
611 questions match, newest first.
527. Deputy Conor Sheehan asked the Minister for Health the way in which the 2026 IPHA Framework Agreement on access to new and innovative medicines which aims for a 180-day decision timeline is being applied to the drug Skyclarys used to treat Friedrich's ataxia to prevent further delays in addressing the unmet need of sufferers; and if she will make a statement on the matter. [17919/26]
528. Deputy Conor Sheehan asked the Minister for Health the number of persons who cannot be discharged from a hospital on delayed discharge of care due to the fact they do not have a fixed abode, by name of hospital, in 2024, 2025 and to date in 2026, in tabular form; and if she will make a statement on the matter. [17929/26]
529. Deputy Máire Devine asked the Minister for Health whether statistics are held by her Department regarding the number of residents in Ireland diagnosed with Tourette's syndrome; and the number of adults and minors respectively. [17933/26]
530. Deputy Michael Murphy asked the Minister for Health if she is aware of the case of a child whose application for placement (details supplied) was refused solely on jurisdictional grounds despite the absence of any equivalent specialised preschool provision in their own catchment area; whether CHO boundary rules override clinical recommendations in such circumstances; the mechanism which exist to permit cross-bou…
531. Deputy Darren O'Rourke asked the Minister for Health if she will address concerns raised by LGBTQ+ families around the assisted human reproduction legislation, particularly around the lack of recognition for families formed through regulated and safeguarded international surrogacy, if they reside abroad; the exclusion of same-sex female couples who conceived without clinical assistance, post May 2020; and if she…
532. Deputy Darren O'Rourke asked the Minister for Health if she will address concerns from the assisted human reproduction legislation particularly around parental recognition made contingent on the surrogate’s post birth consent; and if she will make a statement on the matter. [17941/26]
533. Deputy Darren O'Rourke asked the Minister for Health if the assisted human reproduction legislation fully support the rights of children and parents and comply with Ireland’s obligations under the European Convention on Human Rights; and if she will make a statement on the matter. [17942/26]
534. Deputy Aengus Ó Snodaigh asked the Minister for Health further to the publication of the draft National Drugs Strategy 2026–2029, the proposed governance, funding flows and accountability arrangements for the regional structures within the HSE health regions; whether Local Drug and Alcohol Task Forces will retain independent governance and decision-making authority over locally delivered programmes; and if she w…
535. Deputy Aengus Ó Snodaigh asked the Minister for Health the way in which funding will be allocated within the proposed regional structures under the draft National Drugs Strategy 2026–2029; whether deprivation, social exclusion and patterns of entrenched drug-related harm will be formally weighted alongside population in determining resource allocation; and if she will publish the criteria to be used by HSE healt…
536. Deputy Aengus Ó Snodaigh asked the Minister for Health the specific measures which will be put in place to protect the independent, community-led role of Local Drug and Alcohol Task Forces under the proposed regional governance arrangements in the draft National Drugs Strategy 2026–2029; and if she will make a statement on the matter. [17950/26]
537. Deputy Aengus Ó Snodaigh asked the Minister for Health whether, under the proposed regional structures in the draft National Drugs Strategy 2026–2029, all public funding for community-based drug services, including Local Drug and Alcohol Task Forces, will be pooled at HSE Health region level; the safeguards which will be put in place to prevent dilution of funding to areas of high deprivation; and if she will ma…
538. Deputy Alan Kelly asked the Minister for Health if she will intervene to ensure that the HSE prioritises a conclusion to the Skyclarys reimbursement negotiations, given that it is the only available treatment for this progressive disease, which currently can be classed as having an ‘unmet need’ as outlined in the National Rare Disease Strategy 2025 – 2030; and if she will make a statement on the matter. [17958/2…
539. Deputy Alan Kelly asked the Minister for Health her views on whether the current delay regarding the Skyclarys reimbursement negotiations aligns with the "equitable access" promised in the newly launched National Rare Disease Strategy 2025-2030; and if she will make a statement on the matter. [17959/26]
540. Deputy Darren O'Rourke asked the Minister for Health to provide further clarification and reasoning behind the changes within the HSE to the employment opportunities for paramedics; if she will ensure that the 80 paramedics who have recently qualified will be guaranteed permanent contracts, given they had been informed that would happen at the beginning of their contracts; if she has considered reversing the cha…
541. Deputy Paula Butterly asked the Minister for Health if she will consider introducing full State funding for the shingles (herpes zoster) vaccine for all adults aged 60 and over, in light of the current out-of-pocket cost of approximately €500, which places it beyond the reach of many older people; and to outline her Department's assessment of international models, including the United Kingdom and Australia, wher…
542. Deputy Catherine Ardagh asked the Minister for Health further to the publication of the draft National Drugs Strategy 2026–2029, to outline the proposed governance, funding flows and accountability arrangements for the regional structures within the HSE Health Regions; whether Local Drug and Alcohol Task Forces will retain independent governance and decision-making authority over locally delivered programmes; an…
543. Deputy Catherine Ardagh asked the Minister for Health the way in which funding will be allocated within the proposed regional structures under the draft National Drugs Strategy 2026–2029; whether deprivation, social exclusion and patterns of entrenched drug-related harm will be formally weighted alongside population in determining resource allocation; and if she will publish the criteria to be used by HSE Health…
544. Deputy Catherine Ardagh asked the Minister for Health the specific measures which will be put in place to protect the independent, community-led role of Local Drug and Alcohol Task Forces under the proposed regional governance arrangements in the draft National Drugs Strategy 2026–2029; and if she will make a statement on the matter. [17966/26]
545. Deputy Catherine Ardagh asked the Minister for Health whether, under the proposed regional structures in the draft National Drugs Strategy 2026–2029, all public funding for community-based drug services, including Local Drug and Alcohol Task Forces, will be pooled at HSE Health Region level; the safeguards which will be put in place to prevent dilution of funding to areas of high deprivation; and if she will mak…
546. Deputy Mark Wall asked the Minister for Health further to the publication of the draft National Drugs Strategy 2026–2029, to outline the proposed governance, funding flows and accountability arrangements for the regional structures within the HSE Health Regions; whether Local Drug and Alcohol Task Forces will retain independent governance and decision-making authority over locally delivered programmes; and if sh…
547. Deputy Mark Wall asked the Minister for Health the way in which funding will be allocated within the proposed regional structures under the draft National Drugs Strategy 2026–2029; whether deprivation, social exclusion and patterns of entrenched drug-related harm will be formally weighted alongside population in determining resource allocation; and if she will publish the criteria to be used by HSE Health Region…
548. Deputy Mark Wall asked the Minister for Health the specific measures which will be put in place to protect the independent, community-led role of Local Drug and Alcohol Task Forces under the proposed regional governance arrangements in the draft National Drugs Strategy 2026–2029; and if she will make a statement on the matter. [17971/26]
549. Deputy Mark Wall asked the Minister for Health whether, under the proposed regional structures in the draft National Drugs Strategy 2026–2029, all public funding for community-based drug services, including Local Drug and Alcohol Task Forces, will be pooled at HSE Health Region level; the safeguards which will be put in place to prevent dilution of funding to areas of high deprivation; and if she will make a sta…
550. Deputy Noel McCarthy asked the Minister for Health further to Parliamentary Question No. 253 of 25 February 2026, to provide further clarity on the reason such pain relief is not considered under the drugs payment scheme; the current assessment of Versatis plasters is under the scheme; if there have been any exceptional circumstances where these plasters have been approved for unlicensed use; and if she will mak…